🚀 Introducing H-optimus-1: the leading foundation model for histology, developed by Bioptimus. Learn more about H-optimus-1: Explore our multimodal foundation model:

🥇 H-optimus-1 ranks, on average, highest among its peers in the HEST task as well as in slide and tile-level tasks. Deep-dive into the metrics that underpin H-optimus-1’s category-leading performance in our new technical blog. Read the blog here:

The model advances precision medicine and research via critical applications:. 🧬 Biomarker discovery & patient stratification.💊 Drug discovery & preclinical validation.👩‍🔬 Accelerating clinical trials & regulatory approvals.🔬 Enhancing digital pathology & AI-assisted diagnosis.

Trained on over 1 million whole-slide images from 800,000+ patients, H-optimus-1 sets a new performance benchmark in computational pathology.

📰 @frenchweb ranks Bioptimus #3 in the WE INNOVATE 500 Startups for 2025. We're pioneering a multi-scale, multi-modal foundation model for biology. We're not just building technology, we're creating a new paradigm for biological innovation.

🧩 Could AI help us understand the science of life?. Zelda Mariet, Bioptimus��� Co-Founder & Principal Research Scientist, takes the stage at @tedxparis to explore how foundation models are set to transform medicine. Watch the full talk →

🧬 Can you envision a future where AI connects the dots across biology, from DNA to patients, microbes to medicine? Our Co-Founder & Principal Research Scientist, Zelda Mariet, takes the stage 🎙️ at @tedxparis to explore how foundation models are set to revolutionize medicine.

Our Co-Founder & Principal Research Scientist, Zelda Mariet, joins Heather Couture on the Impact AI podcast to discuss Bioptimus, #biology, and #foundationmodels. 🎧 Listen now:

RT @OwkinScience: 🎥 What were we striving for with our Glioblastoma Moonshot Hackathon? Why did we focus on Glioblastoma? Why do we think A….

🇫🇷 @bfmbusiness spotlights Bioptimus among France's hottest AI startups at #AIActionSummit. 🎧 Listen to the episode:

RT @OwkinScience: We’re excited to share our latest work in collaboration with @bioptimus_ai, published as a pre-print on arXiv. Large fou….

Announcing H0-mini, our latest collaborative work with Owkin, built by applying distillation techniques to H-optimus-0. H0-mini reduces model size by several orders of magnitude and achieves comparable performance and excellent robustness. Read on arxiv:

Next month, we're sponsoring the AI Hackathon for Glioblastoma Research, taking place on February 3-4, 2025 in Paris. This unique two-day event, presented by @Servier and @OwkinScience, will bring together 100 global experts to tackle one of the deadliest forms of brain cancer.

📰 Read the press release:

🎉 Excited to share that we've just hit a remarkable $76M funding milestone, with a $41M round led by @Cathayinnov. We’re grateful to our incredible team, investors, and partners who believe in our mission to build the world's first universal AI foundation model for biology. 🚀

RT @OwkinScience: 🚨 Calling data scientists, bioinformaticians & glioblastoma researchers!. Applications are OPEN for the AI Hackathon for….

Sending warm holiday wishes from all of us at Bioptimus!. May you and your loved ones have a safe and happy holiday season. ❄️☃️

#SLUSH24: Our Founding Chief Operating Officer, Mathilda Strom, took to the stage to spotlight Bioptimus and our groundbreaking efforts in building a pioneering AI foundation model for biology. 🧬. 🎥 Watch the video below.

Our Founding Chief Operating Officer, Mathilda Strom, takes the stage of #SLUSH24 to talk Bioptimus and how we are building a pioneering AI #foundationmodel for biology. 🧬

Join the Bioptimus team at @SlushHQ on November 20 in Helsinki! 🇫🇮. Connect with Bioptimus’ COO, Mathilda Strom, to discover how we’re developing a pioneering AI foundation model that connects biology across all scales—from molecules to cells, tissues, and entire organisms.